These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22273980)

  • 21. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M; Welberg LA; Capuron L; Miller AH; Pagnoni G; Reeves WC
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive function in unaffected twins discordant for affective disorder.
    Christensen MV; Kyvik KO; Kessing LV
    Psychol Med; 2006 Aug; 36(8):1119-29. PubMed ID: 16734950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association study between plasma GDNF and cognitive function in late-onset depression.
    Wang X; Hou Z; Yuan Y; Hou G; Liu Y; Li H; Zhang Z
    J Affect Disord; 2011 Aug; 132(3):418-21. PubMed ID: 21524799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Markers of cognitive vulnerability in major depression].
    Sárosi A; Balogh G; Székely A; Sasvári M; Faludi G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):183-8. PubMed ID: 18510262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological profiles in MCI and in depression: Differential cognitive dysfunction patterns or similar final common pathway disorder?
    Zihl J; Reppermund S; Thum S; Unger K
    J Psychiatr Res; 2010 Jul; 44(10):647-54. PubMed ID: 20060127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder.
    Oral E; Canpolat S; Yildirim S; Gulec M; Aliyev E; Aydin N
    Brain Res Bull; 2012 Aug; 88(5):454-9. PubMed ID: 22498307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Deficits in memory retrieval: an argument in favor of frontal subcortical dysfunction in depression].
    Fossati P; Deweer B; Raoux N; Allilaire JF
    Encephale; 1995; 21(4):295-305. PubMed ID: 7588169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of MMP genes in recurrent depressive disorders and cognitive functions.
    Bobińska K; Szemraj J; Gałecki P; Talarowska M
    Acta Neuropsychiatr; 2016 Aug; 28(4):221-31. PubMed ID: 26856768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The overlap of cognitive impairment in depression and schizophrenia: a comparative study.
    Soštarič M; Zalar B
    Psychiatr Danub; 2011 Sep; 23(3):251-6. PubMed ID: 21963692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.
    Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
    J Affect Disord; 2011 Mar; 129(1-3):175-82. PubMed ID: 20888049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Working memory and executive functions in hyperthyroid patients with Graves' disease].
    Jabłkowska K; Karbownik-Lewińska M; Nowakowska K; Junik R; Lewiński A; Borkowska A
    Psychiatr Pol; 2008; 42(2):249-59. PubMed ID: 19697530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression.
    Talarowska M; Szemraj J; Kowalczyk M; Gałecki P
    Med Sci Monit; 2016 Jan; 22():152-60. PubMed ID: 26768155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults.
    Castaneda AE; Marttunen M; Suvisaari J; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Lönnqvist J; Tuulio-Henriksson A
    Psychol Med; 2010 Jan; 40(1):29-39. PubMed ID: 19413917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder.
    Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
    Neurosci Lett; 2010 Dec; 486(3):184-7. PubMed ID: 20869428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.